1Kobierski J, Emerich J, Krolikowska B, et al. Lymph node metastasis as a prognostic factor in cervical carcinoma. Ginekol Pol, 2002, 73(11):925-929.
2Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002, 2(3):161-174.
3Zhao H, Bemardo MM, Osenkowski P,et al. Differential inhibition of membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 Activation. J Biol Chem, 2004, 279(10): 8592-8601.
4Tam EM, Moore TR, Butler GS, et al. Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP). J Biol Chem, 2004, 279(41):43336-43344.
5Visse R, Nagase H. Matrix metallo- proteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry(Review).Circulation Res, 2003, 92(8):827-839.
6Yoshizaki T, Sato H, Furukawa M. Recent advances in the regulation of matrix metalloproteinase 2 activation : From basic research to clinical implication (Review). Oncol Rep, 2002, 9(3):607-611.
7Sato T, Sakai T, Noguchi Y, et al. Tumor- stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metallo- proteinases.Gynecol Oncol, 2004, 92(1):47-56.
8Lochter A, Galosy S, MuschlerJ, et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol, 1997, 139(7):1861-1872.
9Noe V, Fingleton B, Jacobs K, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci,2001, 114(pt 1):111-118.
10Bemardo MM, Fridman R. TIMP-2 (tissueinhibitor of metalloproteinase-2)regulates MMP-2 (matrix metallo-proteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1(membrane type 1)-MMP. Biochem J, 2003, 374(pt 3):739-745.
6Shao W,Wang W,Xiong XG,et al.Prognostic impact of MMP-2 and MMP--9 expression in pathologic stage I A non- small cell lung cancer[J].J Surg Oncol,2011,104(12) :841- 846.
